ACT Capital Management »

Abivax SA F shares owned by ACT Capital Management

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by ACT Capital Management from 13F filings

Historical chart of ACT Capital Management investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by ACT Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by ACT Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $8.6M 64k 134.86

More positions owned by ACT Capital Management

Krystal Biotech (KRYS)
Chevron Corporation (CVX)
Exxon Mobil Corporation (XOM)
Abivax Sponsored Ads (ABVX)
Tg Therapeutics (TGTX)
Viking Therapeutics (VKTX)
Celcuity (CELC)
Amazon (AMZN)
Nuvation Bio Com Cl A (NUVB)
Arrowhead Pharmaceuticals (ARWR)
Cytokinetics (CYTK)
Celcuity Inc Com Mar 20 26 $50 Call Option
Structure Therapeutics Sponsored Ads (GPCR)
Grayscale Bitcoin Trust Etf Shs Rep Com Ut (GBTC)
Figure Technology Solutions Com Cl A (FIGR)

View all positions for ACT Capital Management

Top funds holding Abivax SA F

TCG Crossover Management
UBS Group
Darwin Global Management
Point72 Asset Management
Vestal Point Capital
Susquehanna International
Caligan Partners
FMR
Paradigm Biocapital Advisors
Cormorant Asset Management
ADAR1 Capital Management
Barclays
Millennium Management
Westfield Capital Management Company
Adage Capital Partners GP

View all funds holding Abivax SA F